The University of Chicago Header Logo

Connection

Rifat Hasina to Tumor Burden

Back to Details
This is a "connection" page, showing publications Rifat Hasina has written about Tumor Burden.
Rifat Hasina
Connection Strength
0.050
Tumor Burden
  1. Dramatic antitumor effects of the dual MET/RON small-molecule inhibitor LY2801653 in non-small cell lung cancer. Cancer Res. 2014 Feb 01; 74(3):884-95.
    View in: PubMed
    Score: 0.025
  2. The EphB4 receptor tyrosine kinase promotes lung cancer growth: a potential novel therapeutic target. PLoS One. 2013; 8(7):e67668.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.